Peptıde Targeted Core Cross-lınked Mıcelles For Dox Delıvery To Her2 Expressıng Cancer Cells
| dc.contributor.author | Bayram, Nazende Nur | |
| dc.contributor.author | Ulu, Gizem Tuğçe | |
| dc.contributor.author | Gürdap, Seda | |
| dc.contributor.author | İşoğlu, İsmail Alper | |
| dc.contributor.author | Baran, Yusuf | |
| dc.contributor.author | Dinçer İşoğlu, Sevil | |
| dc.date.accessioned | 2022-10-25T08:35:39Z | |
| dc.date.available | 2022-10-25T08:35:39Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | In this study, we prepared a novel targeted and extra stable micellar nanocarrier that can facilitate intracellular drug release. First, ((N-3-sulfopropyl-N, N-dimethylammonium)ethyl methacrylate was synthesized by RAFT polymerization, and it was followed by copolymerization of macroCTA with AEM in the presence of an aciddegradable cross-linker. Then, a peptide estimated by phage display for HER-2 recognition was incorporated into these core cross-linked micelles with carbodiimide reaction. | en_US |
| dc.identifier.doi | 10.1089/ten.tea.2022.29025.abstracts | en_US |
| dc.identifier.issn | 1937-3341 | |
| dc.identifier.issn | 1937-335X | |
| dc.identifier.uri | https://hdl.handle.net/11147/12553 | |
| dc.language.iso | en | en_US |
| dc.publisher | Mary Ann Liebert | en_US |
| dc.relation | Tissue Engineering: Part A | en_US |
| dc.relation | TERMIS: 6th World Congress 2021 | en_US |
| dc.relation.ispartof | Tissue Engineering Part A | |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Breast cancer | en_US |
| dc.subject | Core cross-linked micelles | en_US |
| dc.subject | HER2 targeting | en_US |
| dc.title | Peptıde Targeted Core Cross-lınked Mıcelles For Dox Delıvery To Her2 Expressıng Cancer Cells | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication | |
| gdc.author.id | 0000-0001-9265-9985 | |
| gdc.author.id | 0000-0002-1056-4673 | |
| gdc.author.id | 0000-0001-9265-9985 | en_US |
| gdc.author.id | 0000-0002-1056-4673 | en_US |
| gdc.author.institutional | Ulu, Gizem Tuğçe | |
| gdc.author.institutional | Baran, Yusuf | |
| gdc.bip.impulseclass | C5 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C5 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::conference output | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İzmir Institute of Technology. Molecular Biology and Genetics | en_US |
| gdc.description.endpage | 1 | |
| gdc.description.issue | S1 | en_US |
| gdc.description.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q2 | |
| gdc.description.startpage | S | |
| gdc.description.volume | 28 | en_US |
| gdc.description.wosquality | Q3 | |
| gdc.identifier.openalex | W4226061155 | |
| gdc.identifier.wos | WOS:000821187302189 | |
| gdc.index.type | WoS | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 0.0 | |
| gdc.oaire.influence | 2.635068E-9 | |
| gdc.oaire.isgreen | false | |
| gdc.oaire.popularity | 2.2369273E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 0301 basic medicine | |
| gdc.oaire.sciencefields | 0303 health sciences | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.openalex.collaboration | International | |
| gdc.openalex.fwci | 0.0 | |
| gdc.openalex.normalizedpercentile | 0.08 | |
| gdc.opencitations.count | 0 | |
| gdc.plumx.mendeley | 22 | |
| gdc.plumx.patentfamcites | 1 | |
| gdc.wos.citedcount | 0 | |
| relation.isAuthorOfPublication.latestForDiscovery | 7bb863bb-9384-4a07-9fbb-b9c1ab7634a3 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 9711dc3e-de1f-44ab-8c8a-00d8a2db8ba5 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ten.tea.2022.29025.abstracts.pdf
- Size:
- 49.2 KB
- Format:
- Adobe Portable Document Format
- Description:
- Meeting Abstract
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 3.2 KB
- Format:
- Item-specific license agreed upon to submission
- Description: